Pancreatic cancer (PC) has a poor prognosis owing to difficulties in the diagnosis of resectable PC at early stages. Several clinical studies have indicated that the detection and surgery of small resectable pc (<1 cm) can significantly improve survival; however, imaging diagnosis and accurate resection of small pc remain challenging. Here, we report the feasibility of "immuno-openpet" as a novel approach enabling not only early diagnosis but also image-guided surgery, using a small (<1 cm) resectable PC orthotopic xenograft mouse model. for immuno-openpet, we utilized our original openpet system, which enables high-resolution positron emission tomography (pet) imaging with depth-of-interaction detectors, as well as real-time image-guided surgery, by arranging the detectors to create an open space for surgery and accelerating the image reconstruction process by graphics processing units. for immuno-openpet, 64 cu-labeled anti-epidermal growth factor receptor antibody cetuximab was intraperitoneally administered into mice. It clearly identified PC tumors ≥3 mm. In contrast, neither openpet with intravenous-administered 64 cu-cetuximab nor intraperitoneal/intravenous-administered 18 f-fDG (a traditional pet probe) could detect pc in this model. immuno-openpet-guided surgery accurately resected small PC in mice and achieved significantly prolonged survival. This technology could provide a novel diagnostic and therapeutic strategy for small resectable pc to improve patient survival.